UNSPSC 51192002: Colchicine

This classification denotes a colchicine-site binding agent with the molecular formula C22H25NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SML2Y3J35T, chemically known as colchicine, (+)- but generally known as colchicine, which bears US NIH Compound Identifier 2833. European Medicines Agency schedules Colchicine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01420MIG. World Health Organization schedules colchicine in its Anatomical Therapeutic Chemical (ATC) Classification.

Most nations schedule colchicine under HS 29399990 and SITC 54149. As of Q4 2014, COLCHICINE remains the US FDA Preferred Term for this commodity. Colchicine bears US NLM identifiers UMLS ID C0009262 and NCI Concept Code C385. SMILES: O(C1C2C(CCC(NC(=O)C)C3C2CCC(OC)C(=O)C3)CC(OC)C1OC)C.

UNSPSC 51192002 Colchicine, a Commodity code, shows minimal alignment with actual state and local procurement activity. The three recent opportunities posted under this code span athletic training services (Tucson Fire and Police), general medical aid supplies (Tampa Fire Rescue), and pharmacy benefit program capabilities (Texas HHS Commission), none of which involve colchicine or pharmaceutical product sourcing in any concrete form. The athletic training solicitation from the City of Tucson, posted May 13, 2026 with proposals due June 9, 2026, sought injury prevention and rehabilitation services for public safety personnel — a healthcare service delivery model entirely disconnected from pharmaceutical procurement. The Tampa Fire Rescue medical aid supplies ITB, posted April 24, 2026 with bid opening April 9, 2025 (an apparent date error in the source), covered bandages, antiseptic sprays, hydrogen peroxide, aspirin, and emergency blankets — first-aid consumables, not prescription pharmaceuticals. The Texas HHS Commission's RFI posted April 3, 2026 explored direct-to-manufacturer prescription fulfillment strategies but did not reference colchicine or any specific drug product.

The geographic spread captured here includes Arizona, Florida, and Texas, but the code assignment appears to reflect a data classification error rather than genuine colchicine procurement activity. No recent state or local opportunities explicitly solicit colchicine products, pharmaceutical distribution, or related pharmaceutical services. The code does not support a meaningful business development profile for vendors supplying or managing colchicine to state and local health systems, fire departments, or public health agencies.